PARP inhibitors decrease response to subsequent platinum-based chemotherapy in BRCA mutated ovarian cancer patients

Gynecologic Oncology - Tập 162 - Trang S226-S227 - 2021
Peter Rose1
1The Cleveland Clinic Foundation, Cleveland, OH, United States